Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity |
Investigator |
Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| CF Learning Network: Implementation Phase | Grant | $48,496.00 | Research | Cori Daines | Pediatrics | Cincinnati Children's Hospital Medical Center | 04/2020 |
| Dissemination and Implementation of QT Risk Clinical Decision Support | Grant | $236,079.00 | Research | Craig Heise | COM Phx Internal Medicine | University of Utah | 07/2020 |
| Clinical Decision Support System Initiate: Precision Medicine through Pharmacogenomics and Decision Support | Grant | $1,500,000.00 | Research | Craig Heise | COM Phx Internal Medicine | Flinn Foundation | 03/2022 |
| PVAHCS IPA -- Lung CA Screening Initiative (VA PI: Samuel Aguayo, MD) | Contract | $8,000.00 | Research | Craig Heise | COM Phx Internal Medicine | Phoenix VA Health Care System | 08/2021 |
| Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk | Grant | $4,900,635.00 | Research | Craig Weinkauf | Surgery | National Institute on Aging | 09/2021 |
| Evaluation of Peripheral Arterial Disease using the Clarifi Imaging System | Contract | $65,213.00 | Research | Craig Weinkauf | Surgery | Modulated Imaging, Inc | 02/2021 |
| Immune Mechanisms of Carotid Plaque Instability | Grant | $75,000.00 | Research | Craig Weinkauf | Surgery | Arizona Biomedical Research Commission | 08/2021 |
| Novel in vitro screening platform to accelerate discovery of preclinical drug candidates for cryptosporidiosis | Cooperative Agreement | $293,949.50 | Research | Curtis Thorne | Cellular & Molecular Medicine | University of Dundee (United Kingdom) | 05/2022 |
| Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer | Grant | $2,392,208.00 | Research | Cynthia Miranti | Cellular & Molecular Medicine | National Cancer Institute | 04/2021 |
| Targeting Bone Metastatic Castration Resistant Prostate Cancer | Grant | $240,000.00 | Research | Cynthia Miranti | Cellular & Molecular Medicine | American Cancer Society | 02/2020 |
| Cost Match Account to 4248410 | Grant | $2,500.00 | Instruction | Cynthia Standley | COM Phx Bioethics Med Humanism | Arizona Commission On the Arts | 02/2020 |
| A Randomized Phase II Trial of the Altering Intake, Managing Symptoms (AIMS) Intervention for Bowel Dysfunction in Rectal Cancer Survivors | Grant | $93,773.00 | Research | Cynthia Thomson | Health Promotion Sciences | Beckman Research Institute of The City of Hope | 02/2022 |
| Catalyzing Communities to Prevent Obesity: A Systems Approach | Grant | $10,000.00 | Other Sponsored Activity | Cynthia Thomson | Health Promotion Sciences | Tufts University | 04/2021 |
| Evaluation of Reglagene Compounds in FRET Based Assay with hTERT Promoter DNA Oligomer Sequence | Contract | $1,240.00 | Research - Industry (62.5% MTDC) | Daekyu Sun | Pharmacology and Toxicology | Reglagene, LLC | 05/2021 |
| Bedside Exclusion of Pulmonary Embolism in Children Without Radiation (BEEPER) | Grant | $304,932.00 | Research | Dale Woolridge | Dept of Emergency Medicine | Indiana University | 02/2021 |
| Neurocognitive and Language Evaluation in the Ato-oxy Treatment for OSA in Children with DS | Grant | $15,000.00 | Research | Daniel Combs | Pediatrics | LuMind Foundation | 06/2020 |
| State Office of Rural Health | Grant | $1,117,050.00 | Other Sponsored Activity | Daniel Derksen | Community Environment & Policy | Health Resources and Services Administration | 06/2021 |
| Gila River Indian Community COVID-19 Consulting & Contact Tracing | Contract | $120,000.00 | Other Sponsored Activity | Daniel Derksen | Community Environment & Policy | Gila River Indian Community | 08/2020 |
| Area Health Education Centers Program COVID | Grant | $95,455.00 | Instruction | Daniel Derksen | AZ Health Education Centers | Health Resources and Services Administration | 06/2020 |
| COVID-19 Health Disparities | Grant | $8,094,106.00 | Other Sponsored Activity | Daniel Derksen | Community Environment & Policy | Arizona Department of Health Services | 09/2021 |
| Role and Mechanism of Blood Pressure Variability in Risk of Heart Failure | Fellowship | $202,062.00 | Research Training | Daniel Nuyujukian | Epidemiology and Biostatistics | National Heart, Lung, and Blood Institute | 01/2021 |
| A Multicenter, Phase 1/2 Study of Selinexor in Combination with Backbone Treatments or Novel Therapies in Patients with Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) | Contract | $541,268.00 | Clinical Trial | Daniel Persky | Cancer Center Division | Karyopharm Therapeutics Inc. | 05/2021 |
| A Phase II Trial of PET-Directed Therapy using AVD (doxorubicin, vinblastine, and dacarbazine) plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin plus Nivolumab... | Contract | $40,100.00 | Clinical Trial | Daniel Persky | Cancer Center Division | Mayo Foundation for Medical Education and Research (Mayo Clinic) | 07/2020 |
| A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above | Contract | $147,691.00 | Clinical Trial | Daniel Persky | Cancer Center Division | Seattle Genetics, Incorporated | 05/2020 |
| A Three-Arm Study of ME-401 Monotherapy in Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Follicular Lymphoma (FL), of ME-401 in Combination... | Contract | $298,700.00 | Clinical Trial | Daniel Persky | Cancer Center Division | Clinipace Worldwide | 07/2020 |